Several other equities analysts have also commented on the stock. Jefferies Group started coverage on shares of Fevertree Drinks in a research report on Friday, January 19th. They issued a buy rating and a GBX 3,000 ($41.45) price objective for the company. Investec reissued a buy rating and set a GBX 2,330 ($32.19) price target on shares of Fevertree Drinks in a research report on Tuesday, December 5th. Finally, Berenberg Bank reissued a buy rating and set a GBX 2,400 ($33.16) price target on shares of Fevertree Drinks in a research report on Monday, November 20th. Three equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Fevertree Drinks presently has a consensus rating of Buy and a consensus target price of GBX 2,366 ($32.69).
Fevertree Drinks (FEVR) opened at GBX 2,705.20 ($37.37) on Tuesday. The company has a market cap of $2,990.00 and a P/E ratio of 8,453.75. Fevertree Drinks has a 1 year low of GBX 1,353.93 ($18.71) and a 1 year high of GBX 2,888.15 ($39.90).
Fevertree Drinks plc is a United Kingdom-based holding and investment company. The Company is a developer and supplier of premium mixer drinks. The Company’s premium mixers consist of a range of all natural carbonated mixers, including Tonics, Ginger Ale, Ginger Beer, Bitter Lemon and Lemonades. The Company sells a range of products under the Fever-Tree brand, which include Indian Tonic Water, Naturally Light Tonic Water, Elderflower Tonic Water, Mediterranean Tonic Water, Ginger Ale, Ginger Beer, Naturally Light Ginger Beer, Bitter Lemon, Sicilian Lemonade, Lemonade, Spring Soda Water and Premium Cola.
Receive News & Ratings for Fevertree Drinks Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fevertree Drinks and related companies with MarketBeat.com's FREE daily email newsletter.